Experimental Oncology

Faculty Members are involved in basic scientific research and translational (bench-to-bedside) research. Research interests include:
  1. Molecular analysis of breast cancer, brain tumours, melanoma, pediatric cancers and blood cancers
  2. Mechanisms underlying the repair of DNA damage caused by ionizing radiation and chemotherapeutic drugs
  3. Cell adhesion, cell migration and metastatic spread
  4. Epigenetics of cancer
  5. Tumour suppressor genes
  6. Tumour targeting viruses as cancer therapeutic agents
  7. Computational biology approaches to drug discovery
  8. Cell cycle regulation
  9. Membrane transporters and their role in drug transport and resistance


Possible areas of graduate research include:

Dr. Vickie Baracos vickie.baracos@ualberta.ca

Muscle atrophy in cancer associated cachexia


Dr. Kristi Baker kbaker2@ualberta.ca

Anti-tumor immunity; genetic instability; colorectal cancer



Dr. Gordon Chan gkc@ualberta.ca

Mitotic cell cycle checkpoint and cancer


Dr. YangXin Fu yangxin@ualberta.ca

Signaling pathways and gene regulation in ovarian cancer and therapeutics


Dr. Armin Gamper gamper@ualberta.ca

DNA damage response: radiation biology



Dr. Roseline Godbout rgodbout@ualberta.ca

Cancer as a developmental disease; retinoblastoma; brain tumors



Dr. Michael Hendzel michael.hendzel@ualberta.ca

Nuclear components; DNA damage response; chromatin-based epigenetic mechanisms



Dr. Mary Hitt mary.hitt@ualberta.ca

Oncolytic viruses; adenovirus replication; gene regulation; RNA interference; gene therapy


Dr. Ismail Ismail iismail@ualberta.ca

Targeting the DNA damage response in B cell malignancies


Dr. Piyush Kumar pkumar@ualberta.ca

Development of Molecular Theranostic (Therapy+Diagnostic) Agents For Cancer Diseases


Dr. John Lewis jdlewis@ualberta.ca

Translational prostate cancer research; nanoparticles, novel therapeutics, in vivo imaging



Dr. David Murray dmurray@ualberta.ca

DNA repair in the response to anti-cancer agents; prediction of patient response to therapy


Dr. Manijeh Pasdar manijeh.pasdar@ualberta.ca

Molecular mechanisms of adhesion-mediated signaling during cell growth and oncogenesis


Dr. Lynne Postovit postovit@ualberta.ca

Adjunct Professor

Environmental control of normal and cancer stem cell plasticity


Dr. Wilson Roa wroa@ualberta.ca

Nono-carrier platforms for therapeutic applications; image guided radiotherapy


Dr. Michael Sawyer msawyer@ualberta.ca

Cell biology, cell signaling and cancer, drug transporters


Dr. Ralf Schirrmacher schirrma@ualberta.ca

Radiopharmaceutical Chemistry, development of PET imaging agents for neuro- and cancer imaging, medicinal chemistry and drug development



Dr. Jack Tuszynski jackt@ualberta.ca

Adjunct Professor

Computational biophysics; rational drug design; pharmacokinetics


Dr. Alan Underhill alan.underhill@ualberta.ca

Transcription factors in melanoma; gene regulation & epigenetics


Dr. Michael Weinfeld mweinfel@ualberta.ca

Detection and repair of DNA damage


Dr. Frank Wuest wuest@ualberta.ca

Probe development for molecular imaging of cancer